These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20560008)

  • 41. Familial hypertrophic cardiomyopathy: clinical features, molecular genetics and molecular genetic testing.
    Taylor MR; Carniel E; Mestroni L
    Expert Rev Mol Diagn; 2004 Jan; 4(1):99-113. PubMed ID: 14711353
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypertrophic Cardiomyopathy: Clinical Update.
    Geske JB; Ommen SR; Gersh BJ
    JACC Heart Fail; 2018 May; 6(5):364-375. PubMed ID: 29655825
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypertrophic Cardiomyopathy　- A Heterogeneous and Lifelong Disease in the Real World.
    Kitaoka H; Kubo T; Doi YL
    Circ J; 2020 Jul; 84(8):1218-1226. PubMed ID: 32669480
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.
    Van Driest SL; Jaeger MA; Ommen SR; Will ML; Gersh BJ; Tajik AJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Aug; 44(3):602-10. PubMed ID: 15358028
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hereditary arrhythmias and cardiomyopathies: decision-making about genetic testing.
    Louis C; Calamaro E; Vinocur JM
    Curr Opin Cardiol; 2018 Jan; 33(1):78-86. PubMed ID: 29059074
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypertrophic Cardiomyopathy in Pregnancy.
    Saberi S
    Cardiol Clin; 2021 Feb; 39(1):143-150. PubMed ID: 33222809
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression.
    Keren A; Syrris P; McKenna WJ
    Nat Clin Pract Cardiovasc Med; 2008 Mar; 5(3):158-68. PubMed ID: 18227814
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model.
    Wordsworth S; Leal J; Blair E; Legood R; Thomson K; Seller A; Taylor J; Watkins H
    Eur Heart J; 2010 Apr; 31(8):926-35. PubMed ID: 20299350
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coexistence of Digenic Mutations in Both Thin (TPM1) and Thick (MYH7) Filaments of Sarcomeric Genes Leads to Severe Hypertrophic Cardiomyopathy in a South Indian FHCM.
    Selvi Rani D; Nallari P; Dhandapany PS; Rani J; Meraj K; Ganesan M; Narasimhan C; Thangaraj K
    DNA Cell Biol; 2015 May; 34(5):350-9. PubMed ID: 25607779
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Utility of genetics for risk stratification in pediatric hypertrophic cardiomyopathy.
    Mathew J; Zahavich L; Lafreniere-Roula M; Wilson J; George K; Benson L; Bowdin S; Mital S
    Clin Genet; 2018 Feb; 93(2):310-319. PubMed ID: 29053178
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy.
    Bos JM; Towbin JA; Ackerman MJ
    J Am Coll Cardiol; 2009 Jul; 54(3):201-11. PubMed ID: 19589432
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MY APPROACH to the athlete with hypertrophic cardiomyopathy.
    Lampert R
    Trends Cardiovasc Med; 2019 Jul; 29(5):312. PubMed ID: 30928314
    [No Abstract]   [Full Text] [Related]  

  • 53. Current perspectives in hypertrophic cardiomyopathy with the focus on patients in the Finnish population: a review.
    Kuusisto J; Sipola P; Jääskeläinen P; Naukkarinen A
    Ann Med; 2016 Nov; 48(7):496-508. PubMed ID: 27460395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Familial hypertrophic cardiomyopathy--a case report].
    Domal-Kwiatkowska D; Glanowska G; Smolik S; Wilczewski P; Mazurek U; Nowalany-Kozielska E; Fudal M; Wodniecki J
    Kardiol Pol; 2006 Nov; 64(11):1287-91. PubMed ID: 17165166
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of centre expertise on the diagnosis and management of hypertrophic cardiomyopathy: A study from the French register of hypertrophic cardiomyopathy (REMY).
    Mirabel M; Damy T; Donal E; Huttin O; Labombarda F; Eicher JC; Cervino C; Laurito M; Offredo L; Tafflet M; Jouven X; Giura G; Desnos M; Jeunemaître X; Empana JP; Charron P; Habib G; Réant P; Hagège A;
    Int J Cardiol; 2019 Jan; 275():107-113. PubMed ID: 30316646
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic evaluation of familial cardiomyopathy.
    Judge DP; Johnson NM
    J Cardiovasc Transl Res; 2008 Jun; 1(2):144-54. PubMed ID: 20559909
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Examining the Psychosocial Impact of Genetic Testing for Cardiomyopathies.
    Wynn J; Holland DT; Duong J; Ahimaz P; Chung WK
    J Genet Couns; 2018 Aug; 27(4):927-934. PubMed ID: 29243008
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microsatellite marker analysis in the treatment and diagnosis of familial hypertrophic cardiomyopathy.
    Smolik S; Domal-Kwiatkowska D; Kapral M; Weglarz L
    Acta Pol Pharm; 2010; 67(6):669-72. PubMed ID: 21229884
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Usefulness of Genetic Testing in Hypertrophic Cardiomyopathy: an Analysis Using Real-World Data.
    Alejandra Restrepo-Cordoba M; Campuzano O; Ripoll-Vera T; Cobo-Marcos M; Mademont-Soler I; Gámez JM; Dominguez F; Gonzalez-Lopez E; Padron-Barthe L; Lara-Pezzi E; Alonso-Pulpon L; Brugada R; Garcia-Pavia P
    J Cardiovasc Transl Res; 2017 Feb; 10(1):35-46. PubMed ID: 28138913
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comprehensive Genetic Testing for Pediatric Hypertrophic Cardiomyopathy Reveals Clinical Management Opportunities and Syndromic Conditions.
    Gal DB; Morales A; Rojahn S; Callis T; Garcia J; Priest JR; Truty R; Vatta M; Nussbaum RL; Esplin ED; Hollander SA
    Pediatr Cardiol; 2022 Mar; 43(3):616-623. PubMed ID: 34714385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.